Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments for severe alopecia areata show promise but lack standard approval.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Cancer prevention has advanced significantly, with some strategies proving successful.

Melanocyte transplantation can safely restore skin color, especially in stable vitiligo, but must be chosen carefully based on the disease phase.

Effective delivery systems are crucial for siRNA hair loss treatments to work better.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Enhancing antioxidant responses can improve treatments for various diseases.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.